
NATURE . COM {
}
Title:
Reversibility and recurrence of IGF-IR-induced mammary tumors | Oncogene
Description:
The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {π}
- Education
- Health & Fitness
- Science
Content Management System {π}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of nature.com audience?
π Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {πΈ}
Display Ads {π―}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {π°}
Display Ads {π―}
$63,100 per month
According to our algorithms, Nature.com's monthly online income from display advertising ranges from $42,042 to $115,616.
Keywords {π}
cancer, article, google, scholar, cas, growth, breast, insulinlike, receptor, factor, res, nature, oncogene, mammary, tumor, human, igfir, access, tumors, expression, cell, content, research, cookies, recurrence, jones, campbell, moorehead, transgenic, privacy, function, signaling, mouse, epithelial, transition, open, nat, type, monoclonal, antibody, pubmed, tumorigenesis, moody, ontario, data, petrik, targeting, development, model, transcriptional,
Topics {βοΈ}
nature portfolio permissions reprints privacy policy nature formalin-fixed paraffin-embedded tissues cancer research society tgf-beta-induced collagen expression c-myc-induced mammary adenocarcinomas advertising igf-ir-induced mammary tumors social media health research p19arf/p53 pathway lesions author information authors mammary gland development anti-igf-ir therapies real-time pcr primer conditional wnt-induced tumorigenesis targeting igf-ir author correspondence tumor-size-dependent regression endocrine-responsive breast cancer springerlink instant access personal data recombinant humanized anti-insulin tumor development igf-ir-independent mechanisms signal transduction function regulates epithelial plasticity data protection permissions invasive breast cancers transgenic mouse model igf-ir-dependent e-cadherin gene expression accelerates mammary tumorigenesis breast cancer cells kinase activity human breast cancer igf-ir dependence igf-ir independence human lung tumors igf-ir signaling igf-ir results growth factor receptor breast cancer panagiotis induces tumor formation metastasizing mammary carcinomas igf-ii mrna privacy
Questions {β}
- Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Reversibility and recurrence of IGF-IR-induced mammary tumors
description:The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
datePublished:2009-04-20T00:00:00Z
dateModified:2009-04-20T00:00:00Z
pageStart:2152
pageEnd:2162
sameAs:https://doi.org/10.1038/onc.2009.79
keywords:
insulin-like growth factor
mammary tumorigenesis
tumor recurrence
epithelial to mesenchymal transition
tumor dormancy
Medicine/Public Health
general
Internal Medicine
Cell Biology
Human Genetics
Oncology
Apoptosis
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig6_HTML.jpg
isPartOf:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Reversibility and recurrence of IGF-IR-induced mammary tumors
description:The type-I insulin-like growth factor receptor (IGF-IR) is frequently overexpressed in breast cancer and therapeutic agents targeting IGF-IR are currently in development. The ultimate success of anti-IGF-IR therapies will depend on the extent to which established tumors remain dependent upon IGF-IR signaling for sustained growth. To investigate the potential benefits and pitfalls of targeting IGF-IR, we used a doxycycline inducible mouse model of IGF-IR initiated breast cancer. We found that downregulation of IGF-IR results in tumor-size-dependent regression to an undetectable state. Partially regressed tumors almost always resumed growth in the absence of doxycycline and a proportion of tumors that regressed to an undetectable state ultimately recurred. This re-emergence of tumor growth in the absence of doxycycline was facilitated by IGF-IR-dependent and IGF-IR-independent mechanisms. Tumor escape from IGF-IR dependence was associated with an epithelial to mesenchymal transition and upregulation of transcriptional repressors of E-cadherin. These results suggest that tumors initiated by IGF-IR have the ability to become independent of this initiating oncogene, and IGF-IR independence is associated with characteristics consistent with an epithelial to mesenchymal transition.
datePublished:2009-04-20T00:00:00Z
dateModified:2009-04-20T00:00:00Z
pageStart:2152
pageEnd:2162
sameAs:https://doi.org/10.1038/onc.2009.79
keywords:
insulin-like growth factor
mammary tumorigenesis
tumor recurrence
epithelial to mesenchymal transition
tumor dormancy
Medicine/Public Health
general
Internal Medicine
Cell Biology
Human Genetics
Oncology
Apoptosis
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fonc.2009.79/MediaObjects/41388_2009_Article_BFonc200979_Fig6_HTML.jpg
isPartOf:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
type:Person
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Oncogene
issn:
1476-5594
0950-9232
volumeNumber:28
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:R A Jones
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:C I Campbell
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:G A Wood
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:J J Petrik
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
name:R A Moorehead
affiliation:
name:Ontario Veterinary College, University of Guelph
address:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
name:Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {π}(127)
- What's the profit of https://link.springer.com/article/10.1038/onc.2009.79?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle?
- Get to know what's the income of https://doi.org/10.1038%2Fnrc2256
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Models%2C%20mechanisms%20and%20clinical%20evidence%20for%20cancer%20dormancy&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2256&volume=7&pages=834-846&publication_year=2007&author=Aguirre-Ghiso%2CJA each month?
- What's the revenue for https://doi.org/10.1038%2Fnrc721?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Endocrine-responsive%20breast%20cancer%20and%20strategies%20for%20combating%20resistance&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc721&volume=2&pages=101-112&publication_year=2002&author=Ali%2CS&author=Coombes%2CRC?
- Find out how much https://doi.org/10.1172%2FJCI114315 earns monthly
- What's the income of http://scholar.google.com/scholar_lookup?&title=Blockade%20of%20the%20type%20I%20somatomedin%20receptor%20inhibits%20growth%20of%20human%20breast%20cancer%20cells%20in%20athymic%20mice&journal=J%20Clin%20Invest&doi=10.1172%2FJCI114315&volume=84&pages=1418-1423&publication_year=1989&author=Arteaga%2CC&author=Kitten%2CK&author=Coronado%2CE?
- How much profit does https://doi.org/10.1038%2Fbjc.1995.484 make?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Mammary%20cancer%20in%20transgenic%20mice%20expressing%20insulin-like%20growth%20factor%20II%20%28IGF-II%29&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.1995.484&volume=72&pages=1189-1193&publication_year=1995&author=Bates%2CP&author=Fisher%2CR&author=Ward%2CA&author=Richardson%2CL&author=Hill%2CDJ&author=Graham%2CCF?
- What's the monthly money flow for https://doi.org/10.1016%2Fj.ccr.2004.10.013?
- How much does http://scholar.google.com/scholar_lookup?&title=Lack%20of%20sustained%20regression%20of%20c-MYC-induced%20mammary%20adenocarcinomas%20following%20brief%20or%20prolonged%20MYC%20inactivation&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2004.10.013&volume=6&pages=577-586&publication_year=2004&author=Boxer%2CRB&author=Jang%2CJW&author=Sintasath%2CL&author=Chodosh%2CLA gross monthly?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14695208 generate?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=A%20fully%20human%20monoclonal%20antibody%20to%20the%20insulin-like%20growth%20factor%20I%20receptor%20blocks%20ligand-dependent%20signaling%20and%20inhibits%20human%20tumor%20growth%20in%20vivo&journal=Cancer%20Res&volume=63&pages=8912-8921&publication_year=2003&author=Burtrum%2CD&author=Zhu%2CZ&author=Lu%2CD&author=Anderson%2CDM&author=Prewett%2CM&author=Pereira%2CDS?
- Get to know https://doi.org/10.1158%2F0008-5472.CAN-04-4602's earnings
- Revenue of http://scholar.google.com/scholar_lookup?&title=Tumor%20development%20by%20transgenic%20expression%20of%20a%20constitutively%20active%20insulin-like%20growth%20factor%20I%20receptor&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-04-4602&volume=65&pages=3781-3787&publication_year=2005&author=Carboni%2CJM&author=Lee%2CAV&author=Hadsell%2CDL&author=Rowley%2CBR&author=Lee%2CFY&author=Bol%2CDK
- What's the income of https://doi.org/10.1158%2F0008-5472.CAN-06-2044?
- How much does http://scholar.google.com/scholar_lookup?&title=Mesenchymal-to-epithelial%20transition%20facilitates%20bladder%20cancer%20metastasis%3A%20role%20of%20fibroblast%20growth%20factor%20receptor-2&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-2044&volume=66&pages=11271-11278&publication_year=2006&author=Chaffer%2CCL&author=Brennan%2CJP&author=Slavin%2CJL&author=Blick%2CT&author=Thompson%2CEW&author=Williams%2CED make?
- How much profit does https://doi.org/10.1038%2Fsj.cgt.7700126 make?
- How much income does http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20human%20breast%20cancer%20cells%20with%20antisense%20RNA%20to%20the%20type%20I%20insulin-like%20growth%20factor%20receptor%20inhibits%20cell%20growth%2C%20suppresses%20tumorigenesis%2C%20alters%20the%20metastatic%20potential%2C%20and%20prolongs%20survival%20in%20vivo&journal=Cancer%20Gene%20Ther&doi=10.1038%2Fsj.cgt.7700126&volume=7&pages=384-395&publication_year=2000&author=Chernicky%2CCL&author=Yi%2CL&author=Tan%2CH&author=Gan%2CSU&author=Ilan%2CJ have?
- Monthly income for https://doi.org/10.1038%2F84691
- How much revenue does http://scholar.google.com/scholar_lookup?&title=c-MYC%20induces%20mammary%20tumorigenesis%20by%20means%20of%20a%20preferred%20pathway%20involving%20spontaneous%20Kras2%20mutations&journal=Nat%20Med&doi=10.1038%2F84691&volume=7&pages=235-239&publication_year=2001&author=D%E2%80%99Cruz%2CCM&author=Gunther%2CEJ&author=Boxer%2CRB&author=Hartman%2CJL&author=Sintasath%2CL&author=Moody%2CSE bring in?
- What's the monthly income of https://doi.org/10.1172%2FJCI33320?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Tumor%20escape%20in%20a%20Wnt1-dependent%20mouse%20breast%20cancer%20model%20is%20enabled%20by%20p19Arf%2Fp53%20pathway%20lesions%20but%20not%20p16%20Ink4a%20loss&journal=J%20Clin%20Invest&doi=10.1172%2FJCI33320&volume=118&pages=51-63&publication_year=2008&author=Debies%2CMT&author=Gestl%2CSA&author=Mathers%2CJL&author=Mikse%2COR&author=Leonard%2CTL&author=Moody%2CSE?
- What's the income of https://link.springer.com/doi/10.1007/s10549-006-9168-1?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=The%20growth%20hormone%20receptor%20antagonist%20pegvisomant%20blocks%20both%20mammary%20gland%20development%20and%20MCF-7%20breast%20cancer%20xenograft%20growth&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-006-9168-1&volume=98&pages=315-327&publication_year=2006&author=Divisova%2CJ&author=Kuiatse%2CI&author=Lazard%2CZ&author=Weiss%2CH&author=Vreeland%2CF&author=Hadsell%2CDL
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9699666 each month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=A%20dominant%20negative%20mutant%20of%20the%20insulin-like%20growth%20factor-I%20receptor%20inhibits%20the%20adhesion%2C%20invasion%20and%20metastasis%20of%20breast%20cancer&journal=Cancer%20Res&volume=58&pages=3353-3361&publication_year=1998&author=Dunn%2CSE&author=Ehrlich%2CM&author=Sharp%2CNJ&author=Keiss%2CK&author=Solomon%2CG&author=Hawkins%2CR produce monthly?
- Discover the revenue of https://doi.org/10.1038%2Fsj.onc.1208429
- Revenue of http://scholar.google.com/scholar_lookup?&title=DeltaEF1%20is%20a%20transcriptional%20repressor%20of%20E-cadherin%20and%20regulates%20epithelial%20plasticity%20in%20breast%20cancer%20cells&journal=Oncogene&doi=10.1038%2Fsj.onc.1208429&volume=24&pages=2375-2385&publication_year=2005&author=Eger%2CA&author=Aigner%2CK&author=Sonderegger%2CS&author=Dampier%2CB&author=Oehler%2CS&author=Schreiber%2CM
- See how much https://doi.org/10.1158%2F1535-7163.MCT-05-0252 makes per month
- Earnings of http://scholar.google.com/scholar_lookup?&title=Novel%20human%20monoclonal%20antibodies%20to%20insulin-like%20growth%20factor%20%28IGF%29-II%20that%20potently%20inhibit%20the%20IGF%20receptor%20type%20I%20signal%20transduction%20function&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-05-0252&volume=5&pages=114-120&publication_year=2006&author=Feng%2CY&author=Zhu%2CZ&author=Xiao%2CX&author=Choudhry%2CV&author=Barrett%2CJC&author=Dimitrov%2CDS
- Revenue of https://link.springer.com/doi/10.1007/BF01807035
- How much does http://scholar.google.com/scholar_lookup?&title=IGF-II%20mRNA%20and%20protein%20are%20expressed%20in%20the%20stroma%20of%20invasive%20breast%20cancers%3A%20an%20in%20situ%20hybridization%20and%20immunohistochemistry%20study&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2FBF01807035&volume=41&pages=43-50&publication_year=1996&author=Giani%2CC&author=Cullen%2CKJ&author=Campani%2CD&author=Rasmussen%2CA net monthly?
- What are the earnings of https://doi.org/10.1002%2Fijc.20543?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=A%20recombinant%20humanized%20anti-insulin-like%20growth%20factor%20receptor%20type%20I%20antibody%20%28h7C10%29%20enhances%20the%20antitumor%20activity%20of%20vinorelbine%20and%20anti-epidermal%20growth%20factor%20receptor%20therapy%20against%20human%20cancer%20xenografts&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.20543&volume=113&pages=316-328&publication_year=2005&author=Goetsch%2CL&author=Gonzalez%2CA&author=Leger%2CO&author=Beck%2CA&author=Pauwels%2CPJ&author=Haeuw%2CJF
- Find out how much https://doi.org/10.1101%2Fgad.1051603 earns monthly
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Impact%20of%20p53%20loss%20on%20reversal%20and%20recurrence%20of%20conditional%20Wnt-induced%20tumorigenesis&journal=Genes%20Dev&doi=10.1101%2Fgad.1051603&volume=17&pages=488-501&publication_year=2003&author=Gunther%2CEJ&author=Moody%2CSE&author=Belka%2CGK&author=Hahn%2CKT&author=Innocent%2CN&author=Dugan%2CKD
- Learn about the earnings of https://doi.org/10.1038%2Fsj.onc.1203386
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Cooperative%20interaction%20between%20mutant%20p53%20and%20des%281-3%29IGF-I%20accelerates%20mammary%20tumorigenesis&journal=Oncogene&doi=10.1038%2Fsj.onc.1203386&volume=19&pages=889-898&publication_year=2000&author=Hadsell%2CDL&author=Murphy%2CKL&author=Bonnette%2CSG&author=Reece%2CN&author=Laucirica%2CR&author=Rosen%2CJM?
- What's the total monthly financial gain of https://doi.org/10.1158%2F1078-0432.CCR-07-1118?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Phase%20I%20dose%20escalation%20study%20of%20the%20anti%20insulin-like%20growth%20factor-I%20receptor%20monoclonal%20antibody%20CP-751%2C871%20in%20patients%20with%20refractory%20solid%20tumors&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1118&volume=13&pages=5834-5840&publication_year=2007&author=Haluska%2CP&author=Shaw%2CHM&author=Batzel%2CGN&author=Yin%2CD&author=Molina%2CJR&author=Molife%2CLR produce monthly?
- How much profit does https://doi.org/10.1016%2FS0140-6736%2897%2910384-1 generate?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Circulating%20concentrations%20of%20insulin-like%20growth%20factor-I%20and%20risk%20of%20breast%20cancer&journal=Lancet&doi=10.1016%2FS0140-6736%2897%2910384-1&volume=351&pages=1393-1396&publication_year=1998&author=Hankinson%2CSE&author=Willett%2CWC&author=Colditz%2CGA&author=Hunter%2CDJ&author=Michaud%2CDS&author=Deroo%2CB?
- Learn how profitable https://doi.org/10.1056%2FNEJMra043186 is on a monthly basis
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Trastuzumab%E2%80%94mechanism%20of%20action%20and%20use%20in%20clinical%20practice&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMra043186&volume=357&pages=39-51&publication_year=2007&author=Hudis%2CCA
- What's the monthly money flow for https://doi.org/10.1002%2Fjcp.21223?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Epithelial-mesenchymal%20and%20mesenchymal-epithelial%20transitions%20in%20carcinoma%20progression&journal=J%20Cell%20Physiol&doi=10.1002%2Fjcp.21223&volume=213&pages=374-383&publication_year=2007&author=Hugo%2CH&author=Ackland%2CML&author=Blick%2CT&author=Lawrence%2CMG&author=Clements%2CJA&author=Williams%2CED?
- How much income does https://doi.org/10.1038%2Fsj.onc.1209955 have?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Transgenic%20overexpression%20of%20IGF-IR%20disrupts%20mammary%20ductal%20morphogenesis%20and%20induces%20tumor%20formation&journal=Oncogene&doi=10.1038%2Fsj.onc.1209955&volume=26&pages=1636-1644&publication_year=2007&author=Jones%2CRA&author=Campbell%2CCI&author=Gunther%2CEJ&author=Chodosh%2CLA&author=Petrik%2CJJ&author=Khokha%2CR earns monthly
- https://doi.org/10.1158%2F1541-7786.MCR-07-2157 income
- How much does http://scholar.google.com/scholar_lookup?&title=Characterization%20of%20a%20novel%20primary%20mammary%20tumor%20cell%20line%20reveals%20that%20cyclin%20D1%20is%20regulated%20by%20the%20type%20I%20insulin-like%20growth%20factor%20receptor&journal=Mol%20Cancer%20Res&doi=10.1158%2F1541-7786.MCR-07-2157&volume=6&pages=819-828&publication_year=2008&author=Jones%2CRA&author=Campbell%2CCI&author=Petrik%2CJJ&author=Moorehead%2CRA pull in?
- What's the monthly income of https://doi.org/10.1073%2Fpnas.0611192104?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=MicroRNA-192%20in%20diabetic%20kidney%20glomeruli%20and%20its%20function%20in%20TGF-beta-induced%20collagen%20expression%20via%20inhibition%20of%20E-box%20repressors&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0611192104&volume=104&pages=3432-3437&publication_year=2007&author=Kato%2CM&author=Zhang%2CJ&author=Wang%2CM&author=Lanting%2CL&author=Yuan%2CH&author=Rossi%2CJJ?
- What's the financial outcome of https://doi.org/10.2325%2Fjbcs.954?
- How much money does http://scholar.google.com/scholar_lookup?&title=Current%20clinical%20trials%20of%20endocrine%20therapy%20for%20breast%20cancer&journal=Breast%20Cancer&doi=10.2325%2Fjbcs.954&volume=14&pages=200-214&publication_year=2007&author=Kurebayashi%2CJ generate?
- What's the income generated by https://doi.org/10.1016%2FS0304-3835%2803%2900159-9 each month?
- http://scholar.google.com/scholar_lookup?&title=The%20insulin-like%20growth%20factor%20system%20and%20cancer&journal=Cancer%20Lett&doi=10.1016%2FS0304-3835%2803%2900159-9&volume=195&pages=127-137&publication_year=2003&author=LeRoith%2CD&author=Roberts%2CCT's revenue stream
- See how much https://doi.org/10.1002%2Fijc.20814 makes per month
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Use%20of%20a%20transgenic%20mouse%20model%20to%20identify%20markers%20of%20human%20lung%20tumors&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.20814&volume=114&pages=977-982&publication_year=2005&author=Linnerth%2CNM&author=Sirbovan%2CK&author=Moorehead%2CRA
- How much revenue does https://doi.org/10.1093%2Fjnci%2F93.24.1852 generate?
- See how much http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor-I%20receptor%20signaling%20and%20resistance%20to%20trastuzumab%20%28Herceptin%29&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F93.24.1852&volume=93&pages=1852-1857&publication_year=2001&author=Lu%2CY&author=Zi%2CX&author=Zhao%2CY&author=Mascarenhas%2CD&author=Pollak%2CM makes per month
- What's the monthly money flow for https://doi.org/10.1016%2FS1535-6108%2804%2900050-9?
- How much does http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20the%20insulin-like%20growth%20factor%20receptor-1%20tyrosine%20kinase%20activity%20as%20a%20therapeutic%20strategy%20for%20multiple%20myeloma%2C%20other%20hematologic%20malignancies%2C%20and%20solid%20tumors&journal=Cancer%20Cell&doi=10.1016%2FS1535-6108%2804%2900050-9&volume=5&pages=221-230&publication_year=2004&author=Mitsiades%2CCS&author=Mitsiades%2CNS&author=McMullan%2CCJ&author=Poulaki%2CV&author=Shringarpure%2CR&author=Akiyama%2CM generate monthly?
- Find out how much https://doi.org/10.1016%2Fj.ccr.2005.07.009 earns monthly
- See how much http://scholar.google.com/scholar_lookup?&title=The%20transcriptional%20repressor%20Snail%20promotes%20mammary%20tumor%20recurrence&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2005.07.009&volume=8&pages=197-209&publication_year=2005&author=Moody%2CSE&author=Perez%2CD&author=Pan%2CTC&author=Sarkisian%2CCJ&author=Portocarrero%2CCP&author=Sterner%2CCJ makes per month
- What's the financial intake of https://doi.org/10.1016%2FS1535-6108%2802%2900212-X?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Conditional%20activation%20of%20Neu%20in%20the%20mammary%20epithelium%20of%20transgenic%20mice%20results%20in%20reversible%20pulmonary%20metastasis&journal=Cancer%20Cell&doi=10.1016%2FS1535-6108%2802%2900212-X&volume=2&pages=451-461&publication_year=2002&author=Moody%2CSE&author=Sarkisian%2CCJ&author=Hahn%2CKT&author=Gunther%2CEJ&author=Pickup%2CS&author=Dugan%2CKD is on a monthly basis
- What's the financial gain of https://doi.org/10.1038%2Fsj.onc.1210379?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Trastuzumab%3A%20triumphs%20and%20tribulations&journal=Oncogene&doi=10.1038%2Fsj.onc.1210379&volume=26&pages=3637-3643&publication_year=2007&author=Nahta%2CR&author=Esteva%2CFJ is on a monthly basis
- How much does https://doi.org/10.1016%2Fj.bcp.2007.10.032 bring in each month?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Expression%20of%20cytochrome%20P450%202A5%20in%20a%20glucose-6-phosphate%20dehydrogenase-deficient%20mouse%20model%20of%20oxidative%20stress&journal=Biochem%20Pharmacol&doi=10.1016%2Fj.bcp.2007.10.032&volume=75&pages=1230-1239&publication_year=2008&author=Nichols%2CKD&author=Kirby%2CGM is on a monthly basis
- How much does https://link.springer.com/doi/10.1007/BF01833331 bring in each month?
- How much does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20IGF-I%20and%20IGF-II%20mRNA%20in%20breast%20tissue&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2FBF01833331&volume=22&pages=31-38&publication_year=1992&author=Paik%2CS pull in monthly?
- Explore the financials of https://doi.org/10.1038%2Fsj.bjc.6690112
- How much does http://scholar.google.com/scholar_lookup?&title=Altered%20expression%20of%20the%20IGF-1%20receptor%20in%20a%20tamoxifen-resistant%20human%20breast%20cancer%20cell%20line&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6690112&volume=79&pages=693-700&publication_year=1999&author=Parisot%2CJP&author=Hu%2CXF&author=DeLuise%2CM&author=Zalcberg%2CJR rake in every month?
- Discover the revenue of https://doi.org/10.1093%2Fnar%2Fgkj155
- How much does http://scholar.google.com/scholar_lookup?&title=RTPrimerDB%3A%20the%20real-time%20PCR%20primer%20and%20probe%20database%2C%20major%20update%202006&journal=Nucleic%20Acids%20Res&doi=10.1093%2Fnar%2Fgkj155&volume=34&pages=D684-D688&publication_year=2006&author=Pattyn%2CF&author=Robbrecht%2CP&author=De%2CPA&author=Speleman%2CF&author=Vandesompele%2CJ net monthly?
- How much does https://doi.org/10.1038%2Fnrc2131 rake in every month?
- How much does http://scholar.google.com/scholar_lookup?&title=Snail%2C%20Zeb%20and%20bHLH%20factors%20in%20tumour%20progression%3A%20an%20alliance%20against%20the%20epithelial%20phenotype%3F&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2131&volume=7&pages=415-428&publication_year=2007&author=Peinado%2CH&author=Olmeda%2CD&author=Cano%2CA bring in each month?
- What's the profit of https://doi.org/10.1073%2Fpnas.0801197105?
- How much does http://scholar.google.com/scholar_lookup?&title=Oncogene%20cooperation%20in%20tumor%20maintenance%20and%20tumor%20recurrence%20in%20mouse%20mammary%20tumors%20induced%20by%20Myc%20and%20mutant%20Kras&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0801197105&volume=105&pages=5242-5247&publication_year=2008&author=Podsypanina%2CK&author=Politi%2CK&author=Beverly%2CLJ&author=Varmus%2CHE pull in monthly?
- How much revenue does https://doi.org/10.1038%2Fnrc1387 bring in?
- How much does http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factors%20and%20neoplasia&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc1387&volume=4&pages=505-518&publication_year=2004&author=Pollak%2CMN&author=Schernhammer%2CES&author=Hankinson%2CSE rake in every month?
- How much money does https://doi.org/10.1002%2F%28SICI%291097-010X%2819980501%29281%3A1%3C43%3A%3AAID-JEZ7%3E3.0.CO%3B2-C make?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Metastasizing%20mammary%20carcinomas%20in%20H19%20enhancers-Igf2%20transgenic%20mice&journal=J%20Exp%20Zool&doi=10.1002%2F%28SICI%291097-010X%2819980501%29281%3A1%3C43%3A%3AAID-JEZ7%3E3.0.CO%3B2-C&volume=281&pages=43-57&publication_year=1998&author=Pravtcheva%2CDD&author=Wise%2CTL
- How much does https://doi.org/10.1016%2FS0140-6736%2804%2916044-3 pull in monthly?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%20%28IGF%29-I%2C%20IGF%20binding%20protein-3%2C%20and%20cancer%20risk%3A%20systematic%20review%20and%20meta-regression%20analysis&journal=Lancet&doi=10.1016%2FS0140-6736%2804%2916044-3&volume=363&pages=1346-1353&publication_year=2004&author=Renehan%2CAG&author=Zwahlen%2CM&author=Minder%2CC&author=O%E2%80%99Dwyer%2CST&author=Shalet%2CSM&author=Egger%2CM
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9515800's gross income?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Elevated%20insulin-like%20growth%20factor%20I%20receptor%20autophosphorylation%20and%20kinase%20activity%20in%20human%20breast%20cancer&journal=Cancer%20Res&volume=58&pages=1159-1164&publication_year=1998&author=Resnik%2CJL&author=Reichart%2CDB&author=Huey%2CK&author=Webster%2CNJG&author=Seely%2CBL
- Discover the revenue of https://doi.org/10.1158%2F1078-0432.CCR-07-1109
- How much does http://scholar.google.com/scholar_lookup?&title=IMC-A12%2C%20a%20human%20IgG1%20monoclonal%20antibody%20to%20the%20insulin-like%20growth%20factor%20I%20receptor&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-1109&volume=13&pages=5549s-5555s&publication_year=2007&author=Rowinsky%2CEK&author=Youssoufian%2CH&author=Tonra%2CJR&author=Solomon%2CP&author=Burtrum%2CD&author=Ludwig%2CDL net monthly?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7757999
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Malignant%20breast%20epithelium%20selects%20for%20insulin-like%20growth%20factor%20II%20expression%20in%20breast%20stroma%3A%20evidence%20for%20paracrine%20function&journal=Cancer%20Res&volume=55&pages=2448-2454&publication_year=1995&author=Singer%2CC&author=Rasmussen%2CA&author=Smith%2CHS&author=Lippman%2CME&author=Lynch%2CHT&author=Cullen%2CKJ
- Financial intake of https://doi.org/10.1056%2FNEJM200103153441101
- How much money does http://scholar.google.com/scholar_lookup?&title=Use%20of%20chemotherapy%20plus%20a%20monoclonal%20antibody%20against%20HER2%20for%20metastatic%20breast%20cancer%20that%20overexpresses%20HER2&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJM200103153441101&volume=344&pages=783-792&publication_year=2001&author=Slamon%2CDJ&author=Leyland-Jones%2CB&author=Shak%2CS&author=Fuchs%2CH&author=Paton%2CV&author=Bajamonde%2CA make?
- What's the income generated by https://doi.org/10.1023%2FA%3A1009523501499 each month?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Function%20of%20the%20IGF-I%20receptor%20in%20breast%20cancer&journal=J%20Mam%20Gland%20Biol%20Neoplasia&doi=10.1023%2FA%3A1009523501499&volume=5&pages=95-105&publication_year=2000&author=Surmacz%2CE
- What's the monthly income of https://doi.org/10.1016%2Fj.bbrc.2007.11.151?
- How much income is http://scholar.google.com/scholar_lookup?&title=Twist%20is%20a%20transcriptional%20repressor%20of%20E-cadherin%20gene%20expression%20in%20breast%20cancer&journal=Biochem%20Biophys%20Res%20Commun&doi=10.1016%2Fj.bbrc.2007.11.151&volume=367&pages=235-241&publication_year=2008&author=Vesuna%2CF&author=van%2CDP&author=Chen%2CJH&author=Raman%2CV earning monthly?
- How much does https://doi.org/10.1016%2Fj.cell.2004.06.006 earn?
- How much money does http://scholar.google.com/scholar_lookup?&title=Twist%2C%20a%20master%20regulator%20of%20morphogenesis%2C%20plays%20an%20essential%20role%20in%20tumor%20metastasis&journal=Cell&doi=10.1016%2Fj.cell.2004.06.006&volume=117&pages=927-939&publication_year=2004&author=Yang%2CJ&author=Mani%2CSA&author=Donaher%2CJL&author=Ramaswamy%2CS&author=Itzykson%2CRA&author=Come%2CC generate?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3180080 generate?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%20II%20mRNA%20expression%20in%20human%20breast%20cancer&journal=Cancer%20Res&volume=48&pages=6691-6696&publication_year=1988&author=Yee%2CD&author=Cullen%2CKJ&author=Paik%2CS&author=Perdue%2CJF&author=Hampton%2CB&author=Schwartz%2CA
- What's the monthly money flow for https://doi.org/10.1210%2Fmend-3-3-509?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20insulin-like%20growth%20factor%20I%20gene%20expression%20in%20malignancy%3A%20evidence%20for%20a%20paracrine%20role%20in%20human%20breast%20cancer&journal=Mol%20Endocrinol&doi=10.1210%2Fmend-3-3-509&volume=3&pages=509-517&publication_year=1989&author=Yee%2CD&author=Paik%2CS&author=Lebovic%2CGS&author=Marcus%2CRR&author=Favoni%2CRE&author=Cullen%2CKJ
- How much income is https://citation-needed.springer.com/v2/references/10.1038/onc.2009.79?format=refman&flavour=references earning monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R%20A%20Jones generate monthly?
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R%20A%20Jones%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C%20I%20Campbell?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C%20I%20Campbell%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=G%20A%20Wood?
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22G%20A%20Wood%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J%20J%20Petrik?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J%20J%20Petrik%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R%20A%20Moorehead pull in?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R%20A%20Moorehead%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- Income figures for https://s100.copyright.com/AppDispatchServlet?title=Reversibility%20and%20recurrence%20of%20IGF-IR-induced%20mammary%20tumors&author=R%20A%20Jones%20et%20al&contentID=10.1038%2Fonc.2009.79©right=Macmillan%20Publishers%20Limited&publication=0950-9232&publicationDate=2009-04-20&publisherName=SpringerNature&orderBeanReset=true
- What's the revenue for https://citation-needed.springer.com/v2/references/10.1038/onc.2009.79?format=refman&flavour=citation?
- How much does https://doi.org/10.1038/s41388-018-0362-5 rake in every month?
- What's the financial outcome of https://doi.org/10.1186/s12943-015-0291-7?
- What's the monthly income of https://doi.org/10.1038/onc.2013.373?
- How much income does https://doi.org/10.1038/onc.2012.4 have?
- What's the financial intake of https://doi.org/10.1007/s12282-011-0299-9?
- How much does https://www.protocols.io/ net monthly?
- Learn how profitable https://www.natureindex.com/ is on a monthly basis
- What's the income of http://www.naturechina.com?
- How much does https://www.natureasia.com/ja-jp gross monthly?
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Prism.js
- Zoom.js
Emails and Hosting {βοΈ}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {π¦}
- Crossref